{"id":"W2588229474","doi":"10.1093/annonc/mdw435.09","title":"CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"North Carolina GlaxoSmithKline Foundation","keywords":"Medicine; Dabrafenib; Trametinib; Internal medicine; Rash; Adverse effect; Refractory (planetary science); Oncology; Gastroenterology; Cancer; Kinase; Vemurafenib; MAPK/ERK pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004752097,0.0004424093,0.001264688,0.0002148756,0.000313288,0.0009402784,0.000290123,0.000459522,0.001352985],"category_scores_gemma":[0.001408255,0.0002443635,0.001165836,0.0003947784,0.0003632656,0.0004168398,0.0002211988,0.001172075,0.0002724096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001309451,"about_ca_system_score_gemma":0.001368471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005158067,"about_ca_topic_score_gemma":0.01470439,"domain_scores_codex":[0.9995353,0.0001721467,0.00004322215,0.00007656316,0.00007452515,0.00009822085],"domain_scores_gemma":[0.9994104,0.0001775281,0.0001492834,0.00004930529,0.00007768019,0.0001358199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09279831,0.002522111,0.5729244,0.002622336,0.01020333,0.007161855,0.001117321,0.001624656,0.03276889,0.0009038365,0.007020546,0.2683324],"study_design_scores_gemma":[0.03402271,0.0879207,0.7320566,0.0008491416,0.01836433,0.02805277,0.001690734,0.001223205,0.02172502,0.0008400383,0.07310464,0.0001502459],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836819,0.01158469,0.0002045813,0.0004770874,0.00005046522,0.0000966276,0.001121802,0.00001419814,0.002768752],"genre_scores_gemma":[0.9931129,0.004524433,0.000306316,0.0004061639,0.00005896333,0.00004064927,0.00104306,0.00001303852,0.000494494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005158067,"threshold_uncertainty_score":0.01025611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05040336938385071,"score_gpt":0.354387140936592,"score_spread":0.3039837715527413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}